These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
304 related articles for article (PubMed ID: 11158338)
1. The CpG island promoter of the human proopiomelanocortin gene is methylated in nonexpressing normal tissue and tumors and represses expression. Newell-Price J; King P; Clark AJ Mol Endocrinol; 2001 Feb; 15(2):338-48. PubMed ID: 11158338 [TBL] [Abstract][Full Text] [Related]
2. Analysis of the human proopiomelanocortin gene promoter in a small cell lung carcinoma cell line reveals an unusual role for E2F transcription factors. Picon A; Bertagna X; de Keyzer Y Oncogene; 1999 Apr; 18(16):2627-33. PubMed ID: 10353606 [TBL] [Abstract][Full Text] [Related]
3. Proopiomelanocortin gene expression and DNA methylation: implications for Cushing's syndrome and beyond. Newell-Price J J Endocrinol; 2003 Jun; 177(3):365-72. PubMed ID: 12773116 [TBL] [Abstract][Full Text] [Related]
4. Epigenetic modulation of tumor suppressor CCAAT/enhancer binding protein alpha activity in lung cancer. Tada Y; Brena RM; Hackanson B; Morrison C; Otterson GA; Plass C J Natl Cancer Inst; 2006 Mar; 98(6):396-406. PubMed ID: 16537832 [TBL] [Abstract][Full Text] [Related]
5. Extensive DNA methylation spanning the Rb promoter in retinoblastoma tumors. Stirzaker C; Millar DS; Paul CL; Warnecke PM; Harrison J; Vincent PC; Frommer M; Clark SJ Cancer Res; 1997 Jun; 57(11):2229-37. PubMed ID: 9187126 [TBL] [Abstract][Full Text] [Related]
6. Hypomethylation in the promoter region of POMC gene correlates with ectopic overexpression in thymic carcinoids. Ye L; Li X; Kong X; Wang W; Bi Y; Hu L; Cui B; Li X; Ning G J Endocrinol; 2005 May; 185(2):337-43. PubMed ID: 15845926 [TBL] [Abstract][Full Text] [Related]
7. Structure of the POMC promoter region in pituitary and extrapituitary ACTH producing tumors. Mönig H; Ali IU; Oldfield EH; Schulte HM Exp Clin Endocrinol; 1993; 101(1):36-8. PubMed ID: 8386673 [TBL] [Abstract][Full Text] [Related]
8. Cytosine methylation represses glutathione S-transferase P1 (GSTP1) gene expression in human prostate cancer cells. Singal R; van Wert J; Bashambu M Cancer Res; 2001 Jun; 61(12):4820-6. PubMed ID: 11406558 [TBL] [Abstract][Full Text] [Related]
9. Cytosine methylation transforms an E2F site in the retinoblastoma gene promoter into a binding site for the general repressor methylcytosine-binding protein 2 (MeCP2). Di Fiore B; Palena A; Felsani A; Palitti F; Caruso M; Lavia P Nucleic Acids Res; 1999 Jul; 27(14):2852-9. PubMed ID: 10390525 [TBL] [Abstract][Full Text] [Related]
10. DNMT1 forms a complex with Rb, E2F1 and HDAC1 and represses transcription from E2F-responsive promoters. Robertson KD; Ait-Si-Ali S; Yokochi T; Wade PA; Jones PL; Wolffe AP Nat Genet; 2000 Jul; 25(3):338-42. PubMed ID: 10888886 [TBL] [Abstract][Full Text] [Related]
11. The essential role of histone H3 Lys9 di-methylation and MeCP2 binding in MGMT silencing with poor DNA methylation of the promoter CpG island. Zhao W; Soejima H; Higashimoto K; Nakagawachi T; Urano T; Kudo S; Matsukura S; Matsuo S; Joh K; Mukai T J Biochem; 2005 Mar; 137(3):431-40. PubMed ID: 15809347 [TBL] [Abstract][Full Text] [Related]
12. Genome-wide profiling of DNA methylation reveals a class of normally methylated CpG island promoters. Shen L; Kondo Y; Guo Y; Zhang J; Zhang L; Ahmed S; Shu J; Chen X; Waterland RA; Issa JP PLoS Genet; 2007 Oct; 3(10):2023-36. PubMed ID: 17967063 [TBL] [Abstract][Full Text] [Related]
13. Selective association of the methyl-CpG binding protein MBD2 with the silent p14/p16 locus in human neoplasia. Magdinier F; Wolffe AP Proc Natl Acad Sci U S A; 2001 Apr; 98(9):4990-5. PubMed ID: 11309512 [TBL] [Abstract][Full Text] [Related]
14. The histone deacetylase inhibitor trichostatin A downregulates human MDR1 (ABCB1) gene expression by a transcription-dependent mechanism in a drug-resistant small cell lung carcinoma cell line model. El-Khoury V; Breuzard G; Fourré N; Dufer J Br J Cancer; 2007 Aug; 97(4):562-73. PubMed ID: 17667922 [TBL] [Abstract][Full Text] [Related]
15. E2F1-mediated human POMC expression in ectopic Cushing's syndrome. Araki T; Liu NA; Tone Y; Cuevas-Ramos D; Heltsley R; Tone M; Melmed S Endocr Relat Cancer; 2016 Nov; 23(11):857-870. PubMed ID: 27935805 [TBL] [Abstract][Full Text] [Related]
16. Functional analysis of the human pro-opiomelanocortin promoter in the small cell lung carcinoma cell line DMS-79. Picon A; Leblond-Francillard M; Raffin-Sanson ML; Lenne F; Bertagna X; de Keyzer Y J Mol Endocrinol; 1995 Oct; 15(2):187-94. PubMed ID: 8800643 [TBL] [Abstract][Full Text] [Related]
17. Transcriptional silencing of the DLC-1 tumor suppressor gene by epigenetic mechanism in gastric cancer cells. Kim TY; Jong HS; Song SH; Dimtchev A; Jeong SJ; Lee JW; Kim TY; Kim NK; Jung M; Bang YJ Oncogene; 2003 Jun; 22(25):3943-51. PubMed ID: 12813468 [TBL] [Abstract][Full Text] [Related]
18. Promoter methylation and silencing of the tissue factor pathway inhibitor-2 (TFPI-2), a gene encoding an inhibitor of matrix metalloproteinases in human glioma cells. Konduri SD; Srivenugopal KS; Yanamandra N; Dinh DH; Olivero WC; Gujrati M; Foster DC; Kisiel W; Ali-Osman F; Kondraganti S; Lakka SS; Rao JS Oncogene; 2003 Jul; 22(29):4509-16. PubMed ID: 12881707 [TBL] [Abstract][Full Text] [Related]
19. Retinoblastoma protein represses transcription by recruiting a histone deacetylase. Magnaghi-Jaulin L; Groisman R; Naguibneva I; Robin P; Lorain S; Le Villain JP; Troalen F; Trouche D; Harel-Bellan A Nature; 1998 Feb; 391(6667):601-5. PubMed ID: 9468140 [TBL] [Abstract][Full Text] [Related]
20. Coordinated changes in DNA methylation and histone modifications regulate silencing/derepression of luteinizing hormone receptor gene transcription. Zhang Y; Fatima N; Dufau ML Mol Cell Biol; 2005 Sep; 25(18):7929-39. PubMed ID: 16135786 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]